The American Kidney Fund (AKF) has awarded an early-career fellowship that will support new research aiming to understand how…
Articles by Marisa Wexler, MS
Inhibikase Therapeutics is meeting with the U.S. Food and Drug Administration (FDA) April 5 to discuss the potential of…
The U.S. Food and Drug Administration (FDA) has approved the under-the-skin injection therapy sotatercept-csrk — to be marketed under the…
An inflammatory protein called CIRP may serve as a marker of pulmonary hypertension (PH) in people with chronic…
After a diagnosis of pulmonary arterial hypertension (PAH), rapidly starting treatment with a combination of therapies — both…
In people with pulmonary hypertension (PH), the endothelial cells that line the inside of blood vessels in the lungs…
People with pulmonary arterial hypertension (PAH) related to use of methamphetamine — a potent stimulant only legally available by…
A protein called SPHK2 helps to drive pulmonary hypertension (PH) by changing the epigenetic profiles of cells in blood…
The Phase 2b portion of the IMPAHCT clinical trial, which is testing multiple doses of the inhaled imatinib formulation AV-101…
Tenax Therapeutics is planning to soon launch a Phase 3 clinical trial of TNX-103, an oral formulation of levosimendan,…
Beyond Air has been given an innovative technology contract from Vizient for its…
Endotronix has been cleared by U.S. regulators to launch a clinical trial testing its Cordella Sensor, an implanted…